Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Adjuvant Therapy for Cow Milk Protein Allergy
NCT06673082Enrolling by invitation
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Dec 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cow's milk allergy (CMA) comparing Zinc Group with Placebo Group (2 arms). Primary endpoint: Cow Milk Related Symptom Score at 2 weeks. Started Dec 2024; status: enrolling by invitation.
02
Drugs
zinc
03
Conditions
cow's milk allergy (CMA)
Beyond the preview
Go deeper on NCT06673082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06673082.